These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Insulin resistance in patients with polycystic ovary syndrome. Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM Ann Med; 2004; 36(6):426-39. PubMed ID: 15513294 [TBL] [Abstract][Full Text] [Related]
26. Ovarian function and obesity--interrelationship, impact on women's reproductive lifespan and treatment options. Rachoń D; Teede H Mol Cell Endocrinol; 2010 Mar; 316(2):172-9. PubMed ID: 19818376 [TBL] [Abstract][Full Text] [Related]
27. Long-term weight maintenance and cardiovascular risk factors are not different following weight loss on carbohydrate-restricted diets high in either monounsaturated fat or protein in obese hyperinsulinaemic men and women. Keogh JB; Luscombe-Marsh ND; Noakes M; Wittert GA; Clifton PM Br J Nutr; 2007 Feb; 97(2):405-10. PubMed ID: 17298712 [TBL] [Abstract][Full Text] [Related]
28. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome. Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906 [TBL] [Abstract][Full Text] [Related]
35. Insulin resistance syndrome and polycystic ovary syndrome: implications for diagnosis and treatment. Tan S; Hahn S; Janssen OE Panminerva Med; 2005 Dec; 47(4):211-7. PubMed ID: 16489320 [TBL] [Abstract][Full Text] [Related]
36. Long-term effects of popular dietary approaches on weight loss and features of insulin resistance. McAuley KA; Smith KJ; Taylor RW; McLay RT; Williams SM; Mann JI Int J Obes (Lond); 2006 Feb; 30(2):342-9. PubMed ID: 16158081 [TBL] [Abstract][Full Text] [Related]
37. Acupuncture in polycystic ovary syndrome: current experimental and clinical evidence. Stener-Victorin E; Jedel E; Mannerås L J Neuroendocrinol; 2008 Mar; 20(3):290-8. PubMed ID: 18047551 [TBL] [Abstract][Full Text] [Related]
38. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Tang T; Glanville J; Hayden CJ; White D; Barth JH; Balen AH Hum Reprod; 2006 Jan; 21(1):80-9. PubMed ID: 16199429 [TBL] [Abstract][Full Text] [Related]
39. The management of insulin resistance in polycystic ovary syndrome. Teede HJ; Hutchison SK; Zoungas S Trends Endocrinol Metab; 2007 Sep; 18(7):273-9. PubMed ID: 17698366 [TBL] [Abstract][Full Text] [Related]
40. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents. Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]